3 C
New York
Tuesday, January 31, 2023

The Street Is Finally Waking Up To Phathom Pharmaceuticals Inc. (NASDAQ: PHAT)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Phathom Pharmaceuticals Inc. (PHAT) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.06, or 0.80%, to $7.58. The Phathom Pharmaceuticals Inc. has recorded 1,900 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3 PHALCON-NERD-301 Trial Evaluating Daily Dosing of Vonoprazan for Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD).

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Stocks Info

Phathom Pharmaceuticals Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $7.52 and fluctuated between $8.07 as its day high and $7.43 as its day low. The current market capitalization of Phathom Pharmaceuticals Inc. is $320.88M. A total of 0.65 million shares were traded on the day, compared to an average of 180.53K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, PHAT has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 3,685 shares. Over the last 12 months, there were 14 BUYs and 3 SELLs from insiders. Insiders purchased 7,522,304 shares during that period but sold 3,703.

In the most recent transaction, Henderson Molly sold 2,159 shares of PHAT for 9.60 per share on Nov 21. After the transaction, the CFO and CBO now owns 43,341 company shares. In a previous transaction on Nov 21, Curran Terrie sold 1,526 shares at 9.60 per share. PHAT shares that President and Chief Executive owns now total 83,720.

Among the insiders who bought shares, Nabulsi Azmi acquired of 20,000 shares on May 16 at a per-share price of $8.16. This resulted in the Chief Operating Officer holding 785,700 shares of PHAT after the transaction. In another insider transaction, Curran Terrie bought 20,500 shares at $7.41 per share on May 13. Company shares held by the President and Chief Executive now total 64,595.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for PHAT in the last 3 months, the mean price target is $23.83 with high estimates of $35.00 and low estimates of $9.00. In terms of 52-week highs and lows, PHAT has a high of $19.95 and a low of $6.09.

As of this writing, PHAT has an earnings estimate of -$1.32 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$1.25 per share and a lower estimate of -$1.46. The company reported an EPS of -$1.07 in the last quarter, which was -10.30% lower than expectations of -$0.97.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PHAT is Overweight with a score of 4.17. A total of 4 analysts rated the stock as Buy while 1 rated it as Overweight while 2 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles